Schizophrenia

N Engl J Med. 1996 Jan 4;334(1):34-41. doi: 10.1056/NEJM199601043340109.
No abstract available

Publication types

  • Review

MeSH terms

  • Antiparkinson Agents / therapeutic use
  • Antipsychotic Agents / administration & dosage
  • Antipsychotic Agents / adverse effects
  • Antipsychotic Agents / therapeutic use*
  • Central Nervous System Agents / adverse effects
  • Central Nervous System Agents / therapeutic use
  • Delayed-Action Preparations
  • Humans
  • Schizophrenia / drug therapy*

Substances

  • Antiparkinson Agents
  • Antipsychotic Agents
  • Central Nervous System Agents
  • Delayed-Action Preparations